Healthcare
Focus on healthcare innovators and established care models
Our capabilities and global platform are unique to the mid-market. With significant experience and deep relationships with corporates and financial sponsors investing in multiple sub-sectors, we are able to deliver tailored and focused advice to clients.
Sub–sectors
Our global Healthcare team has extensive experience across a broad range of healthcare sub-sectors, with a track record in delivering results for clients, anywhere in the world.
-
Care & services
-
Healthcare IT & supply chain
-
Medtech & life sciences
-
Pharma
Industrials
Advised
- Sumitomo Bakelite Co., Ltd.
on its acquisition of remaining 76.95% stake in
- Kawasumi Laboratories, Inc.
Value: ¥27bn
Healthcare
Advised
- Matsumoto kiyoshi Holdings
on the acquisition of a minority stake in
- Cocokara Fine Inc.
Value: $353m
Infrastructure
Advised
- iCon Infrastructure
on the acquisition financing for
- Nua Healthcare
Healthcare
Advised
- Sanofi
on the sale of
- OTC products BoxaGrippal® and Heumann Tee to Angelini Pharma
Value: €47m
Healthcare
Advised
- Almaviva Santé & Antin IP
on the acquisition of
- Turin & Monceau Private Hospitals
Healthcare
Advised
- InformDS Technologies (Doxper)
on a growth equity raise from
- Alkemi Venture Partners, GrowX Ventures and others
Consumer, Leisure & Retail
Advised
- 1mg Technologies
on a Series D investment of $70m from
- Corisol Holdings, IFC and others
Healthcare
Advised
- Taisho Pharmaceutical Holdings
on the acquisition of a minority stake in
- DHG Pharmaceutical
Value: ¥16bn
Healthcare
Advised
- Sumitomo Bakelite
on the acquisition of shares in
- Kawasumi Laboratories
Healthcare
Advised
- Neusoft Medical Systems
on the acquisition of
- Humanscan
Healthcare
Advised
- Chiral Technologies
on the acquisition of
- Arbor Biosciences
Healthcare
Advised
- Tempus Capital and Deutsche Radiologie Holding
on the issuance of an add-on acquisition financing
Healthcare
Advised
- Taisho Pharmaceuticals
on the acquisition of
- UPSA from Bristol-Myers Squibb Company
Value: ¥1.6bn
Select location
- All locations
- Argentina
- Australia
- Austria
- Bahrain
- Belgium
- Bermuda
- Brazil
- Canada
- China
- Colombia
- Costa Rica
- Czech Republic
- Denmark
- El Salvador
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Honduras
- Hungary
- Iceland
- India
- Ireland
- Israel
- Italy
- Jamaica
- Japan
- Jersey
- Latvia
- Lithuania
- Luxembourg
- Malaysia
- Mauritius
- Mexico
- Myanmar
- Netherlands
- Norway
- Philippines
- Poland
- Portugal
- Samoa
- Singapore
- South Korea
- Spain
- Sri Lanka
- Sweden
- Switzerland
- Taiwan
- Thailand
- Tunisia
- United Arab Emirates
- United Kingdom
- United States
- Vietnam
For important information regarding transactions, please see our disclaimer.
Healthcare team
Filter by country
China
France
Germany
Germany
Germany
India
Italy
Japan
Japan
Japan
Japan
Poland
Spain
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
Vietnam
For important information regarding testimonials, please see our disclaimer.
Recent Healthcare News, Deals & Insights
Solutions
Delivering tailored and impactful solutions, DC Advisory leverages product experts across multiple markets – combining M&A, debt, coverage and specific capital raising expertise.
Select a solution
- All solutions
- Solutions
- M&A Advisory
- Debt Advisory & Restructuring
- Private Capital
- Specialist Solutions
- Financial Sponsors
- Asia Access
